ZA978877B - 3-Alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds. - Google Patents
3-Alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds.Info
- Publication number
- ZA978877B ZA978877B ZA9708877A ZA978877A ZA978877B ZA 978877 B ZA978877 B ZA 978877B ZA 9708877 A ZA9708877 A ZA 9708877A ZA 978877 A ZA978877 A ZA 978877A ZA 978877 B ZA978877 B ZA 978877B
- Authority
- ZA
- South Africa
- Prior art keywords
- alkoxyisoxazol
- substituted
- carboxylic acid
- acid compounds
- amino carboxylic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK109296 | 1996-10-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA978877B true ZA978877B (en) | 1998-04-17 |
Family
ID=8100908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9708877A ZA978877B (en) | 1996-10-04 | 1997-10-03 | 3-Alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds. |
Country Status (26)
Country | Link |
---|---|
US (1) | US6200999B1 (cs) |
EP (1) | EP0934286B1 (cs) |
JP (1) | JP2001501630A (cs) |
KR (1) | KR20000048908A (cs) |
CN (1) | CN1238766A (cs) |
AR (1) | AR008880A1 (cs) |
AT (1) | ATE230734T1 (cs) |
AU (1) | AU733004B2 (cs) |
BG (1) | BG103348A (cs) |
BR (1) | BR9712198A (cs) |
CA (1) | CA2268028C (cs) |
CZ (1) | CZ116899A3 (cs) |
DE (1) | DE69718338T2 (cs) |
EA (1) | EA001625B1 (cs) |
ES (1) | ES2189978T3 (cs) |
HU (1) | HUP0000084A3 (cs) |
IL (1) | IL129135A0 (cs) |
IS (1) | IS5009A (cs) |
NO (1) | NO312961B1 (cs) |
NZ (1) | NZ334798A (cs) |
PL (1) | PL332553A1 (cs) |
SK (1) | SK42899A3 (cs) |
TR (1) | TR199900724T2 (cs) |
UA (1) | UA52698C2 (cs) |
WO (1) | WO1998015542A1 (cs) |
ZA (1) | ZA978877B (cs) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA73749C2 (en) * | 1999-11-01 | 2005-09-15 | Diarylenines | |
NZ525016A (en) | 2000-09-15 | 2004-10-29 | Vertex Pharma | Isoxazoles and their use as inhibitors of ERK |
US20040106794A1 (en) * | 2001-04-16 | 2004-06-03 | Schering Corporation | 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
UA78529C2 (en) | 2001-10-10 | 2007-04-10 | Wyeth Corp | Derivatives of [[2-(amino-3,4-dioxo-1-cyclobutene-1-yl)amino]alkyl] acid for treating pain |
US20040152694A1 (en) * | 2003-02-04 | 2004-08-05 | Istvan Kurucz | Methods and compositions for treating inflammatory disorders of the airways |
BRPI0409255A (pt) | 2003-04-09 | 2006-03-28 | Wyeth Corp | derivados de ácido 2-(8,9-dioxo-2,6-diazabi-ciclo(5.2.0)non-1(7)-en-2-il)alquil fosfÈnico e seu uso como antagonistas de receptores de d-asparto de -n-metila (nmda) |
GT200400213A (es) | 2003-10-22 | 2007-09-05 | Metodos para la preparacion del acido {2-[(8,9)-dioxo-2,6-diaza-biciclo[5.2.0]-non-1(7)-en-2-il]etil} fosfonico y esteres del mismo | |
EP1937674A1 (en) * | 2005-10-11 | 2008-07-02 | F.Hoffmann-La Roche Ag | Isoxazole derivatives |
GB2470495B (en) * | 2008-01-16 | 2012-12-26 | Biotechnology Res Corp Ltd | Oxazolidine derivatives as NMDA antagonists |
EP2338492A1 (en) | 2009-12-24 | 2011-06-29 | Universidad del Pais Vasco | Methods and compositions for the treatment of alzheimer |
TW201609719A (zh) * | 2014-05-28 | 2016-03-16 | 美國禮來大藥廠 | 作為TARP-γ8依賴性AMPA受體拮抗劑之6-經取代-3H-1,3-苯并噻唑-2-酮化合物 |
WO2017126197A1 (ja) * | 2016-01-21 | 2017-07-27 | アグロカネショウ株式会社 | 2-アミノニコチン酸ベンジルエステル誘導体の製造方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE65997B1 (en) | 1990-05-11 | 1995-11-29 | Sankyo Co | Piperidyloxy- and quinuclidinyloxy- isoxazole derivatives their preparation and their therapeutic use |
DE69325662T2 (de) | 1992-10-23 | 2000-02-10 | Merck Sharp & Dohme Ltd., Hoddesdon | Dopamin rezeptor subtyp liganden |
DK124393D0 (da) * | 1993-11-03 | 1993-11-03 | Lundbeck & Co As H | Compounds |
-
1997
- 1997-03-10 UA UA99042300A patent/UA52698C2/uk unknown
- 1997-10-03 JP JP10517096A patent/JP2001501630A/ja active Pending
- 1997-10-03 AT AT97942821T patent/ATE230734T1/de not_active IP Right Cessation
- 1997-10-03 KR KR1019990702938A patent/KR20000048908A/ko not_active Application Discontinuation
- 1997-10-03 WO PCT/DK1997/000426 patent/WO1998015542A1/en not_active Application Discontinuation
- 1997-10-03 HU HU0000084A patent/HUP0000084A3/hu unknown
- 1997-10-03 NZ NZ334798A patent/NZ334798A/en unknown
- 1997-10-03 ES ES97942821T patent/ES2189978T3/es not_active Expired - Lifetime
- 1997-10-03 PL PL97332553A patent/PL332553A1/xx unknown
- 1997-10-03 AU AU44517/97A patent/AU733004B2/en not_active Ceased
- 1997-10-03 BR BR9712198-3A patent/BR9712198A/pt unknown
- 1997-10-03 SK SK428-99A patent/SK42899A3/sk unknown
- 1997-10-03 AR ARP970104586A patent/AR008880A1/es not_active Application Discontinuation
- 1997-10-03 ZA ZA9708877A patent/ZA978877B/xx unknown
- 1997-10-03 CN CN97180167A patent/CN1238766A/zh active Pending
- 1997-10-03 TR TR1999/00724T patent/TR199900724T2/xx unknown
- 1997-10-03 US US09/269,356 patent/US6200999B1/en not_active Expired - Fee Related
- 1997-10-03 IL IL12913597A patent/IL129135A0/xx unknown
- 1997-10-03 EP EP97942821A patent/EP0934286B1/en not_active Expired - Lifetime
- 1997-10-03 CZ CZ991168A patent/CZ116899A3/cs unknown
- 1997-10-03 DE DE69718338T patent/DE69718338T2/de not_active Expired - Fee Related
- 1997-10-03 EA EA199900358A patent/EA001625B1/ru not_active IP Right Cessation
- 1997-10-03 CA CA002268028A patent/CA2268028C/en not_active Expired - Fee Related
-
1999
- 1999-03-20 BG BG103348A patent/BG103348A/xx unknown
- 1999-03-23 IS IS5009A patent/IS5009A/is unknown
- 1999-03-30 NO NO19991561A patent/NO312961B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO991561L (no) | 1999-06-04 |
NO312961B1 (no) | 2002-07-22 |
NO991561D0 (no) | 1999-03-30 |
TR199900724T2 (xx) | 1999-06-21 |
US6200999B1 (en) | 2001-03-13 |
AU733004B2 (en) | 2001-05-03 |
AU4451797A (en) | 1998-05-05 |
ES2189978T3 (es) | 2003-07-16 |
EA199900358A1 (ru) | 1999-10-28 |
ATE230734T1 (de) | 2003-01-15 |
CN1238766A (zh) | 1999-12-15 |
NZ334798A (en) | 2000-06-23 |
UA52698C2 (uk) | 2003-01-15 |
EA001625B1 (ru) | 2001-06-25 |
BR9712198A (pt) | 1999-08-31 |
DE69718338D1 (de) | 2003-02-13 |
CA2268028C (en) | 2003-03-18 |
WO1998015542A1 (en) | 1998-04-16 |
HUP0000084A3 (en) | 2001-12-28 |
IL129135A0 (en) | 2000-02-17 |
IS5009A (is) | 1999-03-23 |
PL332553A1 (en) | 1999-09-13 |
KR20000048908A (ko) | 2000-07-25 |
AR008880A1 (es) | 2000-02-23 |
CA2268028A1 (en) | 1998-04-16 |
DE69718338T2 (de) | 2003-10-16 |
EP0934286B1 (en) | 2003-01-08 |
BG103348A (en) | 1999-11-30 |
HUP0000084A2 (hu) | 2000-06-28 |
SK42899A3 (en) | 1999-08-06 |
JP2001501630A (ja) | 2001-02-06 |
CZ116899A3 (cs) | 1999-09-15 |
EP0934286A1 (en) | 1999-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA981602B (en) | Novel hexanoic acid derivatives. | |
ZA9711092B (en) | Novel compounds. | |
ZA99567B (en) | Aryl-acrylic acid esters. | |
GB9626637D0 (en) | Percarboxyilic acid solutions | |
ZA987126B (en) | Aryloxyarylsulfonylamino hydroxamic acid derivatives. | |
ZA9811898B (en) | Anti-Inflammatory Compounds. | |
ZA97912B (en) | Heterocyclic compounds. | |
ZA99680B (en) | Ester compounds. | |
ZA99873B (en) | Novel dihydroxyhexanoic acid derivatives. | |
ZA978877B (en) | 3-Alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds. | |
ZA979617B (en) | Novel heterocyclic compounds. | |
ZA9811758B (en) | Novel compounds. | |
ZA974811B (en) | Novel therapeutic compounds. | |
ZA978226B (en) | Fatty acid treatment. | |
ZA9811503B (en) | Novel compounds. | |
HU9601167D0 (en) | 5-arylisoxazol-4-yl-substituted 2-amino carboxylic acid compounds | |
ZA98868B (en) | Novel compounds. | |
HUP9802329A3 (en) | Carboxylic acid derivatives | |
ZA966396B (en) | Boronic acid derivatives. | |
ZA979404B (en) | Aspirinate compounds. | |
SI0934286T1 (en) | 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds | |
AU5319898A (en) | Glyoxylic acid amides | |
ZA965713B (en) | 5-pyrazolylbenzoic acid derivatives. | |
ZA969259B (en) | Skip. | |
ZA993642B (en) | Ester compounds. |